579 related articles for article (PubMed ID: 34405378)
21. Medical treatment of endometriosis.
Huang HY
Chang Gung Med J; 2008; 31(5):431-40. PubMed ID: 19097589
[TBL] [Abstract][Full Text] [Related]
22. Dienogest reduces endometrioma volume and endometriosis-related pain symptoms.
Uludag SZ; Demirtas E; Sahin Y; Aygen EM
J Obstet Gynaecol; 2021 Nov; 41(8):1246-1251. PubMed ID: 33629621
[TBL] [Abstract][Full Text] [Related]
23. Hormonal drugs for the treatment of endometriosis.
Capezzuoli T; Rossi M; La Torre F; Vannuccini S; Petraglia F
Curr Opin Pharmacol; 2022 Dec; 67():102311. PubMed ID: 36279764
[TBL] [Abstract][Full Text] [Related]
24. The emerging use of aromatase inhibitors for endometriosis treatment.
Nothnick WB
Reprod Biol Endocrinol; 2011 Jun; 9():87. PubMed ID: 21693036
[TBL] [Abstract][Full Text] [Related]
25. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells.
Ichioka M; Mita S; Shimizu Y; Imada K; Kiyono T; Bono Y; Kyo S
J Steroid Biochem Mol Biol; 2015 Mar; 147():103-10. PubMed ID: 25533385
[TBL] [Abstract][Full Text] [Related]
26. [Endometriosis medical treatment: Hormonal treatment for the management of pain and endometriotic lesions recurrence. CNGOF-HAS Endometriosis Guidelines].
Geoffron S; Cohen J; Sauvan M; Legendre G; Wattier JM; Daraï E; Fernandez H; Chabbert-Buffet N
Gynecol Obstet Fertil Senol; 2018 Mar; 46(3):231-247. PubMed ID: 29530557
[TBL] [Abstract][Full Text] [Related]
27. Advances in targeting estrogen synthesis and receptors in patients with endometriosis.
Clemenza S; Vannuccini S; Ruotolo A; Capezzuoli T; Petraglia F
Expert Opin Investig Drugs; 2022 Nov; 31(11):1227-1238. PubMed ID: 36529967
[TBL] [Abstract][Full Text] [Related]
28. Recent knowledge and new pharmaceutical products in potential alleviation of endometriosis.
Vassiliadis S; Athanassakis I
Recent Pat Inflamm Allergy Drug Discov; 2008 Jun; 2(2):128-38. PubMed ID: 19076002
[TBL] [Abstract][Full Text] [Related]
29. Role of medical therapy in the management of uterine adenomyosis.
Vannuccini S; Luisi S; Tosti C; Sorbi F; Petraglia F
Fertil Steril; 2018 Mar; 109(3):398-405. PubMed ID: 29566852
[TBL] [Abstract][Full Text] [Related]
30. Progesterone resistance in endometriosis: origins, consequences and interventions.
Patel BG; Rudnicki M; Yu J; Shu Y; Taylor RN
Acta Obstet Gynecol Scand; 2017 Jun; 96(6):623-632. PubMed ID: 28423456
[TBL] [Abstract][Full Text] [Related]
31. Drug delivery for the treatment of endometriosis and uterine fibroids.
Friend DR
Drug Deliv Transl Res; 2017 Dec; 7(6):829-839. PubMed ID: 28828592
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacotherapy for pelvic endometriosis in women].
Starczewski A; Brodowska A; Brodowski J
Pol Merkur Lekarski; 2009 Mar; 26(153):231-3. PubMed ID: 19388539
[TBL] [Abstract][Full Text] [Related]
33. New developments in the medical treatment of endometriosis.
Bedaiwy MA; Alfaraj S; Yong P; Casper R
Fertil Steril; 2017 Mar; 107(3):555-565. PubMed ID: 28139238
[TBL] [Abstract][Full Text] [Related]
34. Current status and challenges of drug development for hormonal treatment of endometriosis: a systematic review of randomized control trials.
Zajec V; Mikuš M; Vitale SG; D'alterio MN; Gregov M; Šarić MJ; Carugno J; Angioni S; Ćorić M
Gynecol Endocrinol; 2022 Sep; 38(9):713-720. PubMed ID: 35971323
[TBL] [Abstract][Full Text] [Related]
35. The role of pharmacotherapy in the treatment of endometriosis across the lifespan.
Schwartz K; Llarena NC; Rehmer JM; Richards EG; Falcone T
Expert Opin Pharmacother; 2020 Jun; 21(8):893-903. PubMed ID: 32164462
[TBL] [Abstract][Full Text] [Related]
36. Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis.
Kettel LM; Murphy AA; Mortola JF; Liu JH; Ulmann A; Yen SS
Fertil Steril; 1991 Sep; 56(3):402-7. PubMed ID: 1716596
[TBL] [Abstract][Full Text] [Related]
37. Review of Endometriosis Diagnosis through Advances in Biomedical Engineering.
Shah R; Jagani RP
Crit Rev Biomed Eng; 2018; 46(3):277-288. PubMed ID: 30311558
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological treatment of endometriosis: experience with aromatase inhibitors.
Ferrero S; Venturini PL; Ragni N; Camerini G; Remorgida V
Drugs; 2009 May; 69(8):943-52. PubMed ID: 19496625
[TBL] [Abstract][Full Text] [Related]
39. Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis.
Barra F; Scala C; Ferrero S
Expert Opin Drug Metab Toxicol; 2018 Apr; 14(4):399-415. PubMed ID: 29617576
[TBL] [Abstract][Full Text] [Related]
40. Current and emerging treatment options for endometriosis.
Ferrero S; Evangelisti G; Barra F
Expert Opin Pharmacother; 2018 Jul; 19(10):1109-1125. PubMed ID: 29975553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
